Clinical Trial Update: Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 study (ANRS 12146 CARINEMO) comparing nevirapine to efavirenz in HIV-TB co-infected patients has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• EFAVIRENZ (efavirenz)
• NEVIRAPINE (nevirapine)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: Tuberculosis, Aids | Phase 2, Phase 3 | Status: COMPLETED